Playlist


Turkmenistan to Host National Cinema Week Organized by “Turkmenfilm” in February
24 Jan. 09:36In February, Turkmenistan will host a series of large-scale cultural events organized by the Oguzkhan Turkmenfilm Association in celebration of the 35th anniversary of Turkmenistan’s independence. The program will be held at cultural venues in the capital of Turkmenistan and across all regions of the country, featuring conferences, creative events, and a National Cinema Week showcasing films produced during the years of Turkmenistan’s independence.
During a Government meeting of Turkmenistan, Deputy Chair of the Cabinet of Ministers B. Seyidova reported on the schedule and organizational framework of the main February events. It was noted that Turkmenistan plans to hold conferences, creative meetings, briefings, exhibitions, educational outreach activities, as well as music and song programs throughout the month.
The events will be dedicated to the national motto of 2026, “Independent Neutral Turkmenistan — the Homeland of Determined Winged Horses,” and to the Day of the Diplomatic Worker of Turkmenistan. Among the highlights of February will be a concert of melodies from Turkmen films at the Mukams Palace of the State Cultural Center of Turkmenistan, performed by the State Symphony Orchestra of Turkmenistan, along with several other cultural initiatives.
Relevant proposals were submitted for consideration by the President of Turkmenistan. President Serdar Berdimuhamedov emphasized that numerous celebratory events are planned nationwide during the year themed “Independent Neutral Turkmenistan — the Homeland of Determined Winged Horses,” and instructed officials to ensure the high-quality organization of all February activities in Turkmenistan.
Also read


Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
Today in 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.
Also read